Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

597 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
JCS/JSCVS 2018 Guideline on Revascularization of Stable Coronary Artery Disease.
Nakamura M, Yaku H, Ako J, Arai H, Asai T, Chikamori T, Daida H, Doi K, Fukui T, Ito T, Kadota K, Kobayashi J, Komiya T, Kozuma K, Nakagawa Y, Nakao K, Niinami H, Ohno T, Ozaki Y, Sata M, Takanashi S, Takemura H, Ueno T, Yasuda S, Yokoyama H, Fujita T, Kasai T, Kohsaka S, Kubo T, Manabe S, Matsumoto N, Miyagawa S, Mizuno T, Motomura N, Numata S, Nakajima H, Oda H, Otake H, Otsuka F, Sasaki KI, Shimada K, Shimokawa T, Shinke T, Suzuki T, Takahashi M, Tanaka N, Tsuneyoshi H, Tojo T, Une D, Wakasa S, Yamaguchi K, Akasaka T, Hirayama A, Kimura K, Kimura T, Matsui Y, Miyazaki S, Okamura Y, Ono M, Shiomi H, Tanemoto K; Japanese Circulation Society Joint Working Group. Nakamura M, et al. Among authors: ako j. Circ J. 2022 Feb 25;86(3):477-588. doi: 10.1253/circj.CJ-20-1282. Epub 2022 Jan 31. Circ J. 2022. PMID: 35095031 Free article. No abstract available.
Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions.
Otake H, Honda Y, Courtney BK, Shimohama T, Ako J, Waseda K, Macours N, Rogers C, Popma JJ, Abizaid A, Ormiston JA, Spaulding C, Cohen SA, Fitzgerald PJ. Otake H, et al. Among authors: ako j. Circ Cardiovasc Interv. 2011 Apr 1;4(2):146-54. doi: 10.1161/CIRCINTERVENTIONS.110.957175. Epub 2011 Mar 8. Circ Cardiovasc Interv. 2011. PMID: 21386089 Clinical Trial.
Diagnostic implication of change in b-type natriuretic peptide (BNP) for prediction of subsequent target lesion revascularization following silorimus-eluting stent deployment.
Hasumi E, Iwata H, Kohro T, Manabe I, Kinugawa K, Morisaki N, Ando J, Sawaki D, Takahashi M, Fujita H, Yamashita H, Ako J, Hirata Y, Komuro I, Nagai R. Hasumi E, et al. Among authors: ako j. Int J Cardiol. 2013 Sep 30;168(2):1429-34. doi: 10.1016/j.ijcard.2012.12.046. Epub 2013 Jan 7. Int J Cardiol. 2013. PMID: 23302112
Optimal duration of dual antiplatelet therapy following treatment with the endeavor zotarolimus-eluting stent in real-world Japanese patients with coronary artery disease (OPERA): study design and rationale.
Nakamura M, Nanto S, Hirayama A, Takayama T, Nishikawa M, Kimura K, Morita S, Aizawa T, Asano R, Matsumaru Y, Hamada C, Isshiki T; OPERA Steering Committee and Investigators. Nakamura M, et al. Catheter Cardiovasc Interv. 2014 Sep 1;84(3):368-74. doi: 10.1002/ccd.25282. Epub 2013 Dec 31. Catheter Cardiovasc Interv. 2014. PMID: 24382824 Clinical Trial.
597 results